2014
DOI: 10.1371/journal.pntd.0003124
|View full text |Cite|
|
Sign up to set email alerts
|

Use of Humanised Rat Basophilic Leukaemia Cell Line RS-ATL8 for the Assessment of Allergenicity of Schistosoma mansoni Proteins

Abstract: BackgroundParasite-specific IgE is thought to correlate with protection against Schistosoma mansoni infection or re-infection. Only a few molecular targets of the IgE response in S. mansoni infection have been characterised. A better insight into the basic mechanisms of anti-parasite immunity could be gained from a genome-wide characterisation of such S. mansoni allergens. This would have repercussions on our understanding of allergy and the development of safe and efficacious vaccinations against helminthic p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 57 publications
1
20
0
Order By: Relevance
“…IgE poses somewhat of a conundrum for helminth vaccinologists due to its clear association with naturally acquired protection ( 22 , 63 ), but the accompanying risk of vaccinating people with a recombinant protein that is the target of pre-existing IgE responses and poses the risk of inducing atopy ( 64 ), or potentially anaphylaxis. Instead of excluding potentially protective IgG1-inducing antigens that are the targets of parasite-derived IgE in exposed individuals from further vaccine development, we propose that the molecules be assessed for allergenicity through the use of basophil-activation studies, given that the induction of IgE and clinical manifestation of allergy are not mutually inclusive events ( 94 ). Another strategy aimed at minimizing potential allergenicity of helminth proteins involves their fusion to Fcγ, thereby directing the chimeric protein to the negative signaling receptor FcγRIIb expressed on pro-allergic cells ( 95 ).…”
Section: Discussionmentioning
confidence: 99%
“…IgE poses somewhat of a conundrum for helminth vaccinologists due to its clear association with naturally acquired protection ( 22 , 63 ), but the accompanying risk of vaccinating people with a recombinant protein that is the target of pre-existing IgE responses and poses the risk of inducing atopy ( 64 ), or potentially anaphylaxis. Instead of excluding potentially protective IgG1-inducing antigens that are the targets of parasite-derived IgE in exposed individuals from further vaccine development, we propose that the molecules be assessed for allergenicity through the use of basophil-activation studies, given that the induction of IgE and clinical manifestation of allergy are not mutually inclusive events ( 94 ). Another strategy aimed at minimizing potential allergenicity of helminth proteins involves their fusion to Fcγ, thereby directing the chimeric protein to the negative signaling receptor FcγRIIb expressed on pro-allergic cells ( 95 ).…”
Section: Discussionmentioning
confidence: 99%
“…This sensitive RS‐ATL8 assay has since been used for the detection of food or other allergens and is amenable to high throughput format . It has also been suggested for assessment of allergenicity of anti‐schistosome vaccine candidates and for other purposes, as described recently by us …”
Section: The New Generation Of Rbl Cell‐based Modelsmentioning
confidence: 99%
“…We previously demonstrated that M-IPSE activates basophils in vitro through NF-AT (23). This pathway is implicated in basophil and mast cell expression of IL-4, which we have observed in vivo in mice administered H-IPSE H06 (17).…”
Section: Resultsmentioning
confidence: 99%
“…Basophil activation with recombinant M-IPSE, H-IPSE H03 and H-IPSE H06 Basophil activation was quantified as previously described (23). RS-ATL8 cells were cultured in 10 mL MEM (GIBCO, USA), supplemented with 5% vv v/v heat-inactivated FCS (GIBCO, USA), 100 U/mL penicillin, and 100 µg/mL streptomycin (Sigma, UK) and 2 mM L-glutamine (Sigma, UK).…”
Section: Methodsmentioning
confidence: 99%